Close Menu

NEW YORK — The US Food and Drug Administration on Tuesday granted separate Emergency Use Authorizations for molecular SARS-CoV-2 tests developed by Detectachem and Optolane Technologies, as well as a nasal swab self-collection kit from Color Genomics.

Detectachem's MobileDetect Bio BCC19 Test Kit uses reverse transcription loop-mediated isothermal nucleic acid amplification to detect the N and E genes of SARS-CoV-2 in nasopharyngeal, anterior nasal, mid-turbinate nasal, and oropharyngeal swab specimens.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.